CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial Heart Failure With Preserved Ejection Fraction in the Young Cardiac Resynchronization Therapy and Ventricular Tachyarrhythmia Burden A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure Association of Prior Left Ventricular Ejection Fraction With Clinical Outcomes in Patients With Heart Failure With Midrange Ejection Fraction Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction" Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT-HF study

Original Research2021 Apr 6.

JOURNAL:Ann Intern Med. Article Link

In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y

EM DeFilippis, HGC Van Spall. Keywords: anemia, iron-deficiency; ferric compounds; HF; maltose

LINK

Please click on "Article Link" to get access to this article.